Sophie Drapier Selected Research

Apomorphine

1/2022	Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study.
1/2019	New tricks for an old dog: A repurposing approach of apomorphine.
12/2018	Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life.
6/2018	The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.
4/2018	Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.
3/2018	Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease.
1/2017	Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.
6/2016	Quality of life in Parkinson's disease improved by apomorphine pump: the OPTIPUMP cohort study.
9/2015	Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations.
1/2012	Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Drapier Research Topics

Disease

35	Parkinson Disease (Parkinson's Disease) 01/2022 - 09/2003
5	Cognitive Dysfunction 02/2021 - 09/2010
3	Dyskinesias (Dyskinesia) 01/2017 - 01/2015
3	Dystonia (Limb Dystonia) 05/2016 - 04/2005
3	Weight Gain 01/2016 - 10/2009
2	Mental Disorders (Mental Disorder) 06/2018 - 09/2003
1	Dizziness (Lightheadedness) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	REM Sleep Behavior Disorder 11/2021
1	Movement Disorders (Movement Disorder) 11/2021
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2021
1	Huntington Disease (Huntington's Disease) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Consciousness Disorders 01/2019
1	Restless Legs Syndrome (Restless Legs) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Erectile Dysfunction 06/2018
1	Alcoholism (Alcohol Abuse) 06/2018
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 06/2018
1	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2018
1	Ganglion Cysts (Ganglion) 01/2017
1	Myoclonus (Nocturnal Myoclonus) 05/2016
1	Myoclonic dystonia 05/2016
1	Hemorrhage 07/2015
1	Pain (Aches) 07/2015
1	Neurosarcoidosis 07/2015
1	Treatment-Resistant Depressive Disorder 08/2014
1	Conversion Disorder (Astasia Abasia) 01/2013
1	Dementia (Dementias) 07/2012
1	Hypokinesia (Bradykinesia) 07/2012
1	Gambling (Pathological Gambling) 11/2006
1	Guillain-Barre Syndrome 03/2004
1	Disease Progression 03/2004
1	Neurologic Manifestations (Neurological Manifestations) 03/2004

Drug/Important Bio-Agent (IBA)

10	Apomorphine FDA Link 01/2022 - 01/2012
4	Levodopa (L Dopa)FDA LinkGeneric 01/2018 - 09/2003
3	Dihydroxyphenylalanine (Dopa)IBA 01/2017 - 09/2010
3	Dopamine (Intropin)FDA LinkGeneric 01/2014 - 11/2006
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 12/2014
2	Pharmaceutical PreparationsIBA 06/2018 - 10/2009
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018 - 05/2015
2	Methylphenidate (Ritalin)FDA LinkGeneric 05/2015 - 07/2012
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2018
1	EmeticsIBA 06/2018
1	Hypnotics and Sedatives (Sedatives)IBA 06/2018
1	Zonisamide (Zonegran)FDA LinkGeneric 05/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2015
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2012
1	Dopamine Agents (Dopaminergic Agents)IBA 07/2012
1	Autonomic AgentsIBA 04/2005
1	Anesthetics (Anesthetic Agents)IBA 03/2004

Therapy/Procedure

26	Deep Brain Stimulation 01/2022 - 01/2005
7	Therapeutics 01/2017 - 09/2003
4	Contraindications 01/2017 - 09/2010
1	Activities of Daily Living (ADL) 11/2021
1	Anesthesia 06/2018
1	Palliative Care (Palliative Therapy) 06/2018
1	Subcutaneous Infusions 01/2017
1	Local Anesthesia 04/2005
1	Analgesia 03/2004
1	Conduction Anesthesia (Regional Anesthesia) 03/2004
1	Epidural Anesthesia 03/2004
1	Epidural Analgesia 03/2004